CN110478268A - One kind is long-acting to remove eyelid cream and preparation method thereof - Google Patents

One kind is long-acting to remove eyelid cream and preparation method thereof Download PDF

Info

Publication number
CN110478268A
CN110478268A CN201910731700.0A CN201910731700A CN110478268A CN 110478268 A CN110478268 A CN 110478268A CN 201910731700 A CN201910731700 A CN 201910731700A CN 110478268 A CN110478268 A CN 110478268A
Authority
CN
China
Prior art keywords
parts
emulsifier
raw material
long
acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910731700.0A
Other languages
Chinese (zh)
Inventor
杨陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abel Biotechnology (chongqing) Co Ltd
Original Assignee
Abel Biotechnology (chongqing) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abel Biotechnology (chongqing) Co Ltd filed Critical Abel Biotechnology (chongqing) Co Ltd
Priority to CN201910731700.0A priority Critical patent/CN110478268A/en
Publication of CN110478268A publication Critical patent/CN110478268A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Abstract

Long-acting eyelid cream and preparation method thereof is removed the present invention relates to a kind of, this removes tocopherol acetate of the eyelid cream with weight fraction ratio for 0.1-0.4:1.0-3.0:0.01-0.1:1.0-6.0, glycine betaine, hyaluronic acid and caffeine silanol C are as active constituent, it further include following auxiliary material: M68 emulsifier, A165 emulsifier, cetostearyl alcohol, ethylhexyl palmitate, Permethyl 99A, DC345 silicone oil, methyl esters, propyl ester, Laurocapram, xanthan gum, E20 moisturizer, allantoin, glycerol, propylene glycol, EG emulsifier, Turmeric P.E, FKPHL preservative, ceramide, vitamin E.It is provided by the invention it is long-acting go eyelid cream that can effectively eliminate eye pouch, and there is moistening effect.Preparation method simple process provided by the invention, it is environmental-friendly, it is suitble to industrialized production.

Description

One kind is long-acting to remove eyelid cream and preparation method thereof
Technical field
The present invention relates to cosmetic fields, and in particular to one kind is long-acting to remove eyelid cream and preparation method thereof.
Background technique
With the development and progress of society, the diet content of people and the life style of inferior health make long eye pouch crowd quantity Rapid growth, and increasingly rejuvenation.Eye pouch not only influences the image appearance of people, has an effect on the health of people's eye.
In existing life style, the formation of eye pouch is mainly since various factors causes the metabolic function of people to subtract Weak, microcirculation is unsmooth, and the skin around eyes is very thin, and only a quarter of skin of face thickness, fat are easy in the area It accumulates to form eye pouch in domain.Eye pouch can be removed by performing the operation in the prior art, but the potential risk for the method performed the operation is big, price Valuableness, the convalescence after Miles operation are long;Furthermore it is possible to improve eye part skin problem by smearing eye cream, but eye cream on the market is most It is to nourish anti-wrinkle effect, goes the eye cream of eye pouch relatively fewer, really realizes that the eye cream for effectively removing eye pouch is even more very few. Therefore, it is necessary to the eye creams that one kind can safely and effectively remove eye pouch, to meet the needs in market.
Summary of the invention
The problem to be solved by the present invention is that in view of the above shortcomings of the prior art, provide it is a kind of it is long-acting go eyelid cream and Preparation method, it is provided by the invention it is long-acting go eyelid cream formula components safe, convenient for operation, go eye pouch fruit significant, to human body It is without side-effects.
According to an aspect of the present invention, a kind of long-acting eyelid cream, including following raw material of going is provided: active constituent and auxiliary Material, the active constituent includes tocopherol acetate, glycine betaine, hyaluronic acid, caffeine silanol C, the tocopheryl acetate Ester, glycine betaine, hyaluronic acid, caffeine silanol C weight fraction ratio be 0.1-0.4:1.0-3.0:0.01-0.1:1.0- 6.0。
Further, the auxiliary material includes M68 emulsifier, A165 emulsifier, cetostearyl alcohol, and ethylhexyl palmitate is different Dodecane, DC345 silicone oil, methyl esters, propyl ester, Laurocapram, xanthan gum, E20 moisturizer, allantoin, glycerol, propylene glycol, EG Emulsifier, Turmeric P.E, FKPHL preservative, ceramide, vitamin E.
It is further, described that long-acting to remove eyelid cream according to parts by weight include following raw material:
According to another aspect of the present invention, a kind of long-acting preparation method for removing eyelid cream is provided, comprising the following steps:
S1: A group phase raw material and B group phase raw material are respectively heated, and B group phase raw material is added in A group phase raw material, stirring Homogeneous obtains material 1;
S2: material 1 is added in C group phase raw material, homogeneous is stirred, obtains material 2;
S3: cooling material 2 to 18-30 DEG C is added D group phase raw material and is uniformly mixed, obtains material 3;
S4: placing material 3 to room temperature, carries out filling long-acting removing eyelid cream to get described after detection is qualified.
Further, heating temperature described in step S1 is 50-70 DEG C.
Further, homogenizing time described in step S1 is 2-10min.
Further, homogenizing time described in step S2 is 1-5min.
M68 emulsifier, i.e. MONTANOV 68 (manufacturer SEPPIC) are a kind of O/W nonionic glycosyl emulsifiers, main It to be made of the pure and mild cetearyl glucoside of cetearyl alcohol, there is excellent emulsifying capacity, be highly safe simultaneously And stability, it is widely used in cream type skin care item.
A165 emulsifier, i.e. ARLACEL 165 (manufacturer is the big CRODA of Britain's standing grain), are a kind of non-ionic self-emulsifications Glycerin monostearate has splendid stability, and the lotion shape emulsified is fine and smooth bright, and ductility is good, easy to apply.
DC345 silicone oil, i.e. PMX-0345 (manufacturer is DOW CORNING DOW CORNING), mainly by penta poly dimethyl silicon of ring Oxygen alkane, cyclohexasiloxane composition, can be used as the base oil ingredient of cosmetics, and spreadability is good, easy to apply, lubricates and has appropriate Volatility.
Xanthan gum, also known as xanthan gum are a kind of monospore polysaccharides generated by pseudo xanthomonas fermentation, by cabbage black rot Xanthomonas campestris, through aerobic fermentation biotechnology, cuts off 1,6- glycosidic bond, beats using carbohydrate as primary raw material It pays wages after chain, is being bonded to a kind of acidic extracellular heteroglycan of acidity that straight chain forms by Isosorbide-5-Nitrae-.Since it is with macromolecular structure and glue The characteristic of body can be used as emulsifier, stabilizer, gelling thickener etc., be widely used in food, cosmetic field.
E20 moisturizer, i.e. methyl gluceth -20 are moisturizing ingredients derived from a kind of natural glucose, mild stingless Swash, feeling after for skin can be improved, be widely used in cosmetics.
EG emulsifier, mainly by sodium acrylate/sodium acryloyldimethyl taurate copolymers, isohexadecane and polysorbate Ester -80 forms, and thickening property is good between pH value 4-12, and mobility is good, is widely used in cosmetics.
The source of turmeric (CURCUMA LONGA) extract is the dry rhizome of zingiberaceous plant turmeric, the master of the extract Wanting ingredient is curcumin, has the function of reducing total plasma cholesterol, beta lipoprotein, triglycerides and liver cholesterol, and have Anti-inflammatory, oxidation resistant function, has been applied in food, medicine and cosmetics.
FKPHL preservative, i.e. FK-PHL (manufacturer South Korea Sai Nazhen), mainly by decoyl hydroximic acid, 1,3-PD and 1,2 hexylene glycol composition, has the function of spectrum antibacterial, nonirritant, property is mild, can be used in cosmetics.
Caffeine silanol C (Cafeislilane C) (manufacturer France Ai Ximei EXSYMOL), can be by ring glands The effect stimulation solution rouge of glycosides phosphoric acid, by the formation and accumulation of the inhibiting effect reduction triglycerides to lipoprotein lipase, while Skin histology is rebuild, increases real compact skin and anti-inflammatory aspect works.
Compared with prior art, the invention has the following advantages:
For the long-acting raw material for removing eyelid cream provided by the invention to no skin irritation, property is mildly safe, will not cause Quick reaction;The present invention makes obtained eyelid cream to be gone clearly easily to absorb by selecting each concrete component and optimize its proportion.
In the present invention, using tocopherol acetate, glycine betaine, hyaluronic acid, caffeine silanol C as the activity for removing eye pouch Ingredient, wherein tocopherol acetate, caffeine silanol C primarily serve the effect for promoting fat melting, glycine betaine and hyaluronic acid master Play moisture-keeping function.Because the formation of eye pouch is often with the drying and atrophy of eye part skin, the present invention has found in development process, Proportion is tocopherol acetate, glycine betaine, hyaluronic acid, the caffeine silicon of 0.1-0.4:1.0-3.0:0.01-0.1:1.0-6.0 Alkanol C can play synergistic effect, the proportion between the missing of any ingredient or each ingredient during removing eye pouch Change, can all make the significant effect decline of the removal eye pouch of eye cream.
The characteristics of supplementary product kind for being used to prepare eye cream is various, and the present invention is according to main active, reasonable selection phase The auxiliary material answered, the eye cream being prepared can not only play the role of removing eye pouch, also have the effect of replenishing water and preserving moisture, anti-aging, There is advanced use feeling simultaneously.
Preparation process provided by the invention enables each component sufficiently to merge, to play the effect of maximum removal eye pouch Fruit;And preparation process of the invention is generated without exhaust gas, waste liquid, environmentally friendly, simple process is suitble to industrialized production.
Detailed description of the invention
By reading the following detailed description of the preferred embodiment, various other advantages and benefits are common for this field Technical staff will become clear.The drawings are only for the purpose of illustrating a preferred embodiment, and is not considered as to the present invention Limitation.And throughout the drawings, the same reference numbers will be used to refer to the same parts.In the accompanying drawings:
Fig. 1 shows the flow chart of the long-acting preparation method for removing eyelid cream of embodiment according to the present invention.
Specific embodiment
The illustrative embodiments of the disclosure are more fully described below with reference to accompanying drawings.Although showing this public affairs in attached drawing The illustrative embodiments opened, it being understood, however, that may be realized in various forms the disclosure without the reality that should be illustrated here The mode of applying is limited.It is to be able to thoroughly understand the disclosure on the contrary, providing these embodiments, and can be by this public affairs The range opened is fully disclosed to those skilled in the art.
Raw manufacturer/the supplier of the raw material of following example 1-6 and comparative example 1-5 is documented identical with summary of the invention, Do not record manufacturer person be can be by the conventional reagent product of commercially available acquisition;Embodiment 1-3 and comparative example 1-3 is using identical Preparation method, the preparation method being all made of in embodiment 7;Embodiment 4-6 and comparative example 4-5 uses identical preparation method, The preparation method being all made of in embodiment 8.
Embodiment 1-6
Comparative example 1
Except tocopherol acetate is not included in raw material, remaining is same as Example 1.
Comparative example 2
Except glycine betaine is not included in raw material, remaining is same as Example 1.
Comparative example 3
Except hyaluronic acid is not included in raw material, remaining is same as Example 1.
Comparative example 4
Except caffeine silanol C is not included in raw material, remaining is same as Example 1.
Comparative example 5
Except the parts by weight of tocopherol acetate in raw material, glycine betaine, hyaluronic acid, caffeine silanol C are respectively as follows: 0.5,0.5,0.35,5.0, remaining is same as Example 2.
Embodiment 7
Embodiment 1-3 and comparative example 1-3's the preparation method is as follows:
S1: A group phase raw material and B group phase raw material are respectively heated, and heating temperature is 65 DEG C, and A is added in B group phase raw material In group phase raw material, homogeneous 10min is stirred, material 1 is obtained;
S2: material 1 is added in C group phase raw material, homogeneous 2min is stirred, obtains material 2;
S3: 2 to 20 DEG C of material of cooling is added D group phase raw material and is uniformly mixed, obtains material 3;
S4: placing material 3 to room temperature, carry out detection it is qualified after it is filling.
Embodiment 8
Embodiment 4-6 and comparative example 4-5's the preparation method is as follows:
S1: A group phase raw material and B group phase raw material are respectively heated, and heating temperature is 55 DEG C, and A is added in B group phase raw material In group phase raw material, homogeneous 5min is stirred, material 1 is obtained;
S2: material 1 is added in C group phase raw material, homogeneous 5min is stirred, obtains material 2;
S3: 2 to 30 DEG C of material of cooling is added D group phase raw material and is uniformly mixed, obtains material 3;
S4: placing material 3 to room temperature, carry out detection it is qualified after it is filling.
Experimental example efficacy assessments
The eye cream that embodiment 1-6 and comparative example 1-5 are obtained selects 20 subjects to carry out effect assessment, subject year respectively Age 30-55 years old, equal long-term existence eye pouch problem.Application method: after morning and evening face cleaning, taking eye cream appropriate, and point is applied to eye circumference, smears equal It is even, after continuous use 6 weeks, carry out effect assessment.
Evaluation criterion is as follows:
Invalid: eye pouch area is without significant change;
Effective: eye pouch area reduces, and reduces the one third that area is less than former eye pouch area;
Effective: eye pouch area reduces, and reduces the one third that area is greater than former eye pouch area.
Efficacy assessments result is as shown in the table
Effective number of cases Effective number of cases Invalid number of cases
Embodiment 1 10 10 0
Embodiment 2 12 8 0
Embodiment 3 11 9 0
Embodiment 4 13 7 0
Embodiment 5 11 9 0
Embodiment 6 12 8 0
Comparative example 1 13 0 7
Comparative example 2 17 0 3
Comparative example 3 16 0 4
Comparative example 4 11 0 9
Comparative example 5 18 0 2
Evaluation result shows the significant effect of the eye cream removal eye pouch of embodiment 1-6;Tocopherol acetate, glycine betaine, thoroughly Bright matter acid, caffeine silanol C can play synergistic effect during removing eye pouch, by comparative example 1-5 it is found that its In any ingredient missing or each ingredient between proportion change, can all make eye cream removal eye pouch significant effect decline.
The foregoing is only a preferred embodiment of the present invention, but scope of protection of the present invention is not limited thereto, In the technical scope disclosed by the present invention, any changes or substitutions that can be easily thought of by anyone skilled in the art, It should be covered by the protection scope of the present invention.Therefore, protection scope of the present invention should be with the protection model of the claim Subject to enclosing.

Claims (8)

1. one kind is long-acting to remove eyelid cream, which is characterized in that including following raw material: active constituent and auxiliary material, the active constituent packet Include tocopherol acetate, glycine betaine, hyaluronic acid and caffeine silanol C, the tocopherol acetate, glycine betaine, hyalomitome The weight fraction ratio of acid and caffeine silanol C are 0.1-0.4:1.0-3.0:0.01-0.1:1.0-6.0.
2. long-acting as described in claim 1 remove eyelid cream, which is characterized in that the auxiliary material includes M68 emulsifier, A165 emulsification Agent, cetostearyl alcohol, ethylhexyl palmitate, Permethyl 99A, DC345 silicone oil, methyl esters, propyl ester, Laurocapram, xanthan gum, E20 moisturizer, allantoin, glycerol, propylene glycol, EG emulsifier, Turmeric P.E, FKPHL preservative, ceramide, vitamin E。
3. long-acting as claimed in claim 2 remove eyelid cream, which is characterized in that the raw material including following parts by weight:
1.5-2.5 parts of M68 emulsifier, 0.5-1.5 parts of A165 emulsifier, 1.0-3.0 parts of cetostearyl alcohol, ethylhexyl palmitate 3.0-5.0 parts, 3.0-8.0 parts of Permethyl 99A, 2.0-5.0 parts of DC345 silicone oil, 0.05-0.2 parts of methyl esters, 0.05-0.2 parts of propyl ester, 0.1-0.4 parts of tocopherol acetate, 0.5-1.0 parts of Laurocapram, 0.05-0.2 parts of xanthan gum, E20 moisturizer 1.0-3.0 Part, 0.1-0.3 parts of allantoin, 1.0-3.0 parts of glycine betaine, 2.0-4.0 parts of glycerol, 3.0-6.0 parts of propylene glycol, hyaluronic acid 0.01-0.1 parts, 50-70 parts of water, 1.0-2.0 parts of EG emulsifier, 0.2-1.0 parts of Turmeric P.E, FKPHL preservative 0.3-1.5 Part, 1.0-6.0 parts of caffeine silanol C .0-2.0 parts of Cer EOS, 0.5-2.0 parts of vitamin E.
4. long-acting as claimed in claim 2 remove eyelid cream, which is characterized in that the raw material including following parts by weight:
2.0 parts of M68 emulsifier, 1.0 parts of A165 emulsifier, 2.0 parts of cetostearyl alcohol, 4.0 parts of ethylhexyl palmitate, different 12 5.0 parts of alkane, 3.0 parts of DC345 silicone oil, 0.15 part of methyl esters, 0.1 part of propyl ester, 0.2 part of tocopherol acetate, Laurocapram 0.8 Part, 0.1 part of xanthan gum, 2.0 parts of E20 moisturizer, 0.15 part of allantoin, 2.0 parts of glycine betaine, 3.0 parts of glycerol, 5.0 parts of propylene glycol, 0.03 part of hyaluronic acid, 57 parts of water, 1.2 parts of EG emulsifier, 0.5 part of Turmeric P.E, 0.6 part of FKPHL preservative, caffeine silicon 5.0 parts of alkanol C .0 parts of Cer EOS, 1.0 parts of vitamin E.
5. such as the described in any item long-acting preparation methods for removing eyelid cream of claim 3-4, which is characterized in that including following step It is rapid:
Weighing each raw material, A group mutually includes M68 emulsifier, A165 emulsifier, cetostearyl alcohol, ethylhexyl palmitate, and different 12 Alkane, DC345 silicone oil, methyl esters, propyl ester, tocopherol acetate, Laurocapram;
B group mutually includes xanthan gum, E20 moisturizer, allantoin, glycine betaine, glycerol, propylene glycol, hyaluronic acid, water;
C group mutually includes EG emulsifier;
D group mutually includes Turmeric P.E, FKPHL preservative, caffeine silanol C, ceramide, vitamin E;
S1: A group phase raw material and B group phase raw material are respectively heated, and B group phase raw material is added in A group phase raw material, and stirring is equal Matter obtains material 1;
S2: material 1 is added in C group phase raw material, homogeneous is stirred, obtains material 2;
S3: cooling material 2 to 18-30 DEG C is added D group phase raw material and is uniformly mixed, obtains material 3;
S4: placing material 3 to room temperature, carries out filling long-acting removing eyelid cream to get described after detection is qualified.
6. the long-acting preparation method for removing eyelid cream as claimed in claim 5, which is characterized in that heating temperature described in step S1 is 50-70℃。
7. the long-acting preparation method for removing eyelid cream as claimed in claim 5, which is characterized in that homogenizing time described in step S1 is 2-10min。
8. the long-acting preparation method for removing eyelid cream as claimed in claim 5, which is characterized in that homogenizing time described in S2 is 1- 5min。
CN201910731700.0A 2019-08-08 2019-08-08 One kind is long-acting to remove eyelid cream and preparation method thereof Pending CN110478268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910731700.0A CN110478268A (en) 2019-08-08 2019-08-08 One kind is long-acting to remove eyelid cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910731700.0A CN110478268A (en) 2019-08-08 2019-08-08 One kind is long-acting to remove eyelid cream and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110478268A true CN110478268A (en) 2019-11-22

Family

ID=68550313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910731700.0A Pending CN110478268A (en) 2019-08-08 2019-08-08 One kind is long-acting to remove eyelid cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110478268A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023234A1 (en) * 2003-08-29 2005-03-17 Yves Saint Laurent Parfums Molecules exhibiting anti-adipogenic activity on adipocyte human cells
CN105935349A (en) * 2015-03-02 2016-09-14 朴成律 Method for improving skin condition using composition comprising red-wilfordi root and black-ginseng fermentation extract haved skin whitening function
CN108261368A (en) * 2018-02-09 2018-07-10 广州重生化妆品实业有限公司 A kind of compound goes pouch gel and its preparation process
CN109602655A (en) * 2018-12-25 2019-04-12 广州葆妍生物科技有限公司 It is a kind of with it is crease-resistant, remove black eye, the composition for going eye pouch effect and its preparation method and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023234A1 (en) * 2003-08-29 2005-03-17 Yves Saint Laurent Parfums Molecules exhibiting anti-adipogenic activity on adipocyte human cells
CN105935349A (en) * 2015-03-02 2016-09-14 朴成律 Method for improving skin condition using composition comprising red-wilfordi root and black-ginseng fermentation extract haved skin whitening function
CN108261368A (en) * 2018-02-09 2018-07-10 广州重生化妆品实业有限公司 A kind of compound goes pouch gel and its preparation process
CN109602655A (en) * 2018-12-25 2019-04-12 广州葆妍生物科技有限公司 It is a kind of with it is crease-resistant, remove black eye, the composition for going eye pouch effect and its preparation method and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
艾伯尔生物科技(重庆)有限公司: "《艾伯尔生物眼部修护霜(长效型)》", 11 June 2019, 国家药品监督管理局 *
裘炳毅等: "《现代化妆品科学与技术》", 31 March 2016, 中国轻工业出版社 *

Similar Documents

Publication Publication Date Title
JP7230080B2 (en) Skin composition with low pH
EP0646370B1 (en) Cosmetic and dermatological compositions containing an association of ceramides and linoleic acids, their preparation
CN107397714A (en) With anti-blue light contamination and the elite breast of desalination microgroove effect and its preparation and application
KR101964809B1 (en) Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof
CN105902408B (en) Cosmetic composition containing brown alga and red algae essence
KR101987903B1 (en) Cosmetic composition for treating atopic dermatitis and method thereof
WO2008030626A2 (en) Skin compositions containing hydrocortisone
CN109172388A (en) Ceramide III containing liposome has anti-aging, the facial mask liquid of sebum barrier reparation and preparation method thereof
KR101917774B1 (en) A preservative composition of cosmetics comprising Nigella sativa seed extract as an active ingredient
KR20030023398A (en) Composition for external application to the skin containing Opuntia ficus-indica extract
KR102220534B1 (en) Soothing cream and manufacturing method for the same
Lourith et al. Formulation and clinical evaluation of the standardized Litchi chinensis extract for skin hyperpigmentation and aging treatments
TW201642849A (en) Compositions including sesamin, methods of making and using the same in skin anti-aging and skin lightening applications
JP2009007307A (en) Cosmetic or skin preparation for external use
CN110478268A (en) One kind is long-acting to remove eyelid cream and preparation method thereof
DE102009033740A1 (en) Composition, useful for treating cellulite, comprises extract of cedar, preferably Atlas cedar (Cedrus atlantica), extract of mint, preferably spearmint (Mentha spicata) and extract of coffee, preferably green coffee (Coffea arabica)
CN108938464A (en) A kind of mild makeup remover of deep layer cleaning
KR102085052B1 (en) Composition for anti-inflammatory or moisturizing on skin comprising plant extract
CN111184644B (en) Application of artemisinin as antiallergic component in cosmetics
JP2023552814A (en) Method for producing cosmetic composition containing sucrose ester and solvent
CN116583264A (en) Cosmetic composition comprising sucrose ester and solvent
KR101805395B1 (en) Cosmetic composition for skin moisturizing
CN106176345A (en) A kind of containing collagen antioxidant peptides looks improving and the skin nourishing cosmetics and preparation method thereof
JP6779643B2 (en) Topical composition
KR101729279B1 (en) Anti-dark circle composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191122

RJ01 Rejection of invention patent application after publication